In-vivo imaging of tumor associated urokinase-type plasminogen activator activity.

TitleIn-vivo imaging of tumor associated urokinase-type plasminogen activator activity.
Publication TypeJournal Article
Year of Publication2006
AuthorsHsiao J-K, Law B, Weissleder R, Tung C-H
JournalJ Biomed Opt
Volume11
Issue3
Pagination34013
Date Published2006 May-Jun
ISSN1083-3668
KeywordsAdenocarcinoma, Biomarkers, Tumor, Cell Line, Tumor, Enzyme Activation, Fibrosarcoma, Humans, Microscopy, Fluorescence, Neoplasm Proteins, Spectrophotometry, Infrared, Urokinase-Type Plasminogen Activator
Abstract

The ability to image tumor associated protease in vivo has biological and clinical implications. In the present study, we describe the development and validation of a urokinase-type plasminogen activator (uPA) sensitive fluorescence imaging probe. The activation of our probe is highly specific to uPA in both enzymatic and cellular-based assays. In two distinct in-vivo tumor models (human colon adenocarcinoma HT-29 and human fibrosarcoma HT-1080), the observed fluorescence changes correlate well with tumor associated uPA activity. The signal intensities of the tumors are about three-fold higher in animals with probe injections. Our results suggest a direct detection method for uPA activity in vivo and the approach can be used for monitoring tumor growth and development.

DOI10.1117/1.2204029
Alternate JournalJ Biomed Opt
PubMed ID16822063
Grant ListP50-CA86355 / CA / NCI NIH HHS / United States
R01-CA99385 / CA / NCI NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065